S&P 500
7,750.20
-0.46%
Dow Jones
53,464.60
-0.48%
Nasdaq 100
30,000.90
-0.22%
Russell 2000
3,057.82
-0.24%
FTSE 100
10,736.50
-0.21%
Nikkei 225
68,981.20
+0.35%
Ingredion

Ingredion (INGR) Q1 2026 Earnings

Reported May 5, 2026 at 6:08 AM ET · SEC Source

Q1 26 EPS

$2.34

MISS 5.32%

Est. $2.47

Q1 26 Revenue

$1.79B

BEAT +0.22%

Est. $1.79B

vs S&P Since Q1 26

-8.0%

TRAILING MARKET

INGR -1.3% vs S&P +6.8%

Market Reaction

Did INGR Beat Earnings? Q1 2026 Results

Ingredion delivered a disappointing first quarter of 2026, with earnings missing expectations as operational troubles weighed heavily on results. Adjusted diluted EPS came in at $2.34, falling 5.32% short of the $2.47 consensus estimate and down shar… Read more Ingredion delivered a disappointing first quarter of 2026, with earnings missing expectations as operational troubles weighed heavily on results. Adjusted diluted EPS came in at $2.34, falling 5.32% short of the $2.47 consensus estimate and down sharply from $2.97 a year ago, while revenue of $1.79 billion was essentially in line with forecasts despite slipping 1.2% year over year. The primary culprit was a longer-than-expected recovery from production challenges at the company's Argo manufacturing facility, which drove a 63% year-over-year collapse in U.S./CAN segment operating income to $34.00 million and pushed total adjusted operating income down 22% to $212.00 million. The Texture and Healthful Solutions segment offered some relief, posting its eighth consecutive quarter of broad-based volume growth with revenue rising 2% to $617.00 million. With the Argo disruption still casting a shadow, Ingredion lowered its full-year 2026 adjusted EPS guidance to a range of $10.45 to $11.15, and the stock recently touched a 52-week low near $99.97, reflecting investor concern over the company's near-term trajectory.

Key Takeaways

  • • Operational challenges at Argo facility drove significant decline in F&II–U.S./CAN segment operating income
  • • Texture & Healthful Solutions delivered eighth consecutive quarter of volume growth driven by clean label ingredient demand
  • • Mexican peso transactional currency headwinds weighed on F&II–LATAM operating income
  • • Lower volumes and less favorable mix in F&II–U.S./CAN reduced total company net sales
  • • Favorable foreign exchange translation partially offset net sales declines
  • • Improved plant-based protein business performance in All Other segment
24/7 Wall St

INGR YoY Financials

Q1 2026 vs Q1 2025, source: SEC Filings

24/7 Wall St

INGR Revenue by Segment

With YoY comparisons, source: SEC Filings

Q2 25 Q2 26

“While we expected a challenging first quarter after last year's strong first quarter, results were weaker than anticipated in Food & Industrial Ingredients–U.S./CAN due to operational challenges at our Argo facility. At the same time, performance in our Texture & Healthful Solutions and Food & Industrial Ingredients–LATAM segments were in line with our expectations despite an increasingly uncertain macroeconomic environment.”

— Jim Zallie, Q1 2026 Earnings Press Release

Back to INGR Stock Page